Closed access
Author
Date
2013Type
- Doctoral Thesis
ETH Bibliography
yes
Altmetrics
Permanent link
https://doi.org/10.3929/ethz-a-009995268Publication status
publishedExternal links
Search print copy at ETH Library
Publisher
ETHSubject
XENOBIOTIC METABOLISM + XENOBIOTICS; LIPOSOMES + MICELLES (DRUG FORMS); ANIMAL MODELS IN MEDICINE; ANTIDOTISMUS + ENTGIFTUNG + DEKONTAMINATION (PHARMAKOLOGIE); TIERISCHE MODELLE IN DER MEDIZIN; ANTIDOTISM + DETOXIFICATION + DECONTAMINATION (PHARMACOLOGY); LIPOSOMEN + MIZELLEN (ARZNEIFORMEN); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY); INTOXICATION + CLINICAL TOXICOLOGY; XENOBIOTIKA + XENOBIOTIKAMETABOLISMUS; VERGIFTUNG + KLINISCHE TOXIKOLOGIE; ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNGOrganisational unit
02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences02310 - Pharmazie
03811 - Leroux, Jean-Christophe / Leroux, Jean-Christophe
02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.
More
Show all metadata
ETH Bibliography
yes
Altmetrics